スポンサーリンク
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine | 論文
- Renal Transplant Recipient with Chronic Hepatitis C Who Obtained Sustained Viral Response after Interferon-β Therapy
- CASE OF AIDS-RELATED CHOLANGITIS TREATED BY ENDOSCOPIC SPHINCTEROTOMY
- Hepatopulmonary Syndrome in a Patient with Primary Biliary Cirrhosis
- Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis
- Doppler Waveform Pattern Changes in a Patient with Primary Budd-Chiari Syndrome before and after Angioplasty
- Budd-Chiari Syndrome Associated with Hypereosinophilic Syndrome; A Case Report
- Toll-Like Receptor 3 Signaling Induces Chronic Pancreatitis through the Fas/Fas Ligand-Mediated Cytotoxicity
- Characteristics of geographic distributions and route of infection for hepatitis B virus genotype D in Ehime area in western Japan
- Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis
- Change of acute hepatitis B transmission routes in Japan
- Etiology of liver cirrhosis in Japan : a nationwide survey
- Diabetes mellitus reduces the therapeutic effectiveness of interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
- Drug-induced Hepatitis due to Repeated Use of Hair Dye
- Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers
- Evaluating the Role of Rheumatoid Factors for the Development of Rheumatoid Arthritis in a Mouse Model with a Newly Established ELISA System
- Liver/spleen volume ratio as a predictor of prognosis in primary biliary cirrhosis
- Expression of sphingosine kinase 2 in synovial fibroblasts of rheumatoid arthritis contributing to apoptosis by a sphingosine analogue, FTY720
- Amino acid imbalance in patients with chronic liver diseases
- Usefulness of the hyperechoic rim for assessing the therapeutic efficacy of radiofrequency ablation in hepatocellular carcinoma patients
- Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis